Trials / Sponsors / Tcelltech Inc.
Tcelltech Inc.
Industry · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies Relapsed or Refractory Hematologic Malignancies | Phase 1 | 2026-04-15 |
| Recruiting | Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors Solid Tumors | Phase 1 | 2025-10-16 |
| Not Yet Recruiting | Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas Osteosarcoma, Soft Tissue Sarcoma | Phase 1 | 2025-08-20 |
| Recruiting | Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma. High-grade Glioma, WHO Grade Ⅳ Glioma | Phase 1 | 2024-09-04 |